Alginate-degrading bacteriophages as a therapeutic treatment against Pseudomonas aeruginosa in cystic bibrosis by Quiñones Celdran, Daniel & Universitat Autònoma de Barcelona. Facultat de Biociències
Phage 
genome 
algL 
gene 
pUCP18
_TE 
P. aeruginosa 
Co-electroporation 
DNA 
purification 
Genetically-modified phages 
Alginate-degrading bacteriophages as a 
therapeutic treatment against Pseudomonas 
aeruginosa  in cystic fibrosis 
P. aeruginosa 
culture (Pa)  
Phage cocktail (Pc)  
Pa + Pc 
Pc 
ø Syto9 assay 
FDA assay 
incubation 
Continuous flow (0.2 mm/s)  
Fresh sterile 
medium 
Efluent 
Syto9 assay 
FDA assay 
BACKGROUND 
 Pseudomonas aeruginosa can cause up to 20% of nosocomial infections [1]. 
 P. aeruginosa colonize the lung of cystic fibrosis patients. 
 Pseudomonas infections are difficult to control because its resistance to many 
antibiotics and disinfectants, mainly due to efflux pumps an biofilm [2]. 
 Phage therapy has many advantages over antibiotics but needs further research. 
 The use of genetically-modified phages is an interesting site-directed treatment. 
INITIAL HYPOTHESIS AND OBJECTIVES 
 A cocktail composed by P. aeruginosa bacteriophages overexpressing an alginate-
degrading enzyme could be an effective treatment in cystic fibrosis patients colonized 
by this bacterium. 
 The aim of this project is to design a phage cocktail based in several lytic and non-
transductant phages encoding an alginate lyase, and evaluate its safety and 
effectiveness in vitro and in vivo. 
Daniel Quiñones Celdran – Microbiology – Supervised by Jesús Aranda Rodríguez – 31 May 2017 
EXPERIMENTAL DESIGN 
EXPECTED RESULTS 
1· The Step-by-step method (SBS) will be used for the selection of 
infective phages against each resistant strain that could appear. The 
method ends when last phage-resistant mutant is sensible to the first 
phage [3]. 
2· Bacteriophage Recombineering of Electroporated DNA (BRED) will be 
conducted for gene insertion in the phage genome. The genome and the 
desired gene are co-electroporated in a strain with a recombination system 
[4].  
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Figure1. Representation of the SBS method.  Figure2. Representation of BRED Technology. 
Figure3. Diagram of in vitro analysis of early (up) and mature (down) biofilms. Figure4. Diagram of in vivo analysis and treatments.   
3· In vitro biofilm and cell viability analysis will be performed in 
microtiter plates and continuous flow cells. Total biomass quantification 
and cell viability will be determined by Syto9 and FDA assays, respectively. 
4· For in vivo determination of safety and effectiveness, survival rate of mice 
will be determined as well as quantification of cytokines, LDH, phages and 
bacteria in bronchoalveolar fluids.  
 Reduction in viable cell numbers and total biomass in both early and mature 
biofilms. 
 Significant increase in mice survival in the infected and treated group when 
compared with non-treated group. 
 Cytokine and lactate dehydrogenase levels should be reduced, as well as 
bacteriophage and viable cell counts, when compared with non-treated group.  
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